Home
Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 06/03
Trade details
- Type
- Insider sale
- Amount
- $425,109
- Shares · price
- 6,100 sh · $69.69 a share
- Held after
- 767,780 sh
- Trade date
- 26/06/03
- Filed
- 26/06/03
- Days to filing
- 0 days
Sold 0.8% of holdings
- Share of holding sold
- 0.8%
Halozyme Therapeutics trades, last 26 weeks
What else happened in Halozyme Therapeutics around then
Filed or reported within 30 days of the trade day · 05/04~07/03Helen Torley's recent trades
- Helen Torley
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 planHalozyme Therapeutics
HALO
$23.7M
240,000 sh
$23.7M
Filed 08/17
Traded 08/17
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$1.1M
16,600 sh
$1.1M
Filed 06/03
Traded 06/02
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$875.6K
12,989 sh
$875.6K
Filed 06/03
Traded 06/01
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$369.2K
5,401 sh
$369.2K
Filed 06/03
Traded 06/01
- Helen Torley
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 planHalozyme Therapeutics
HALO
$227K
3,400 sh
$227K
Filed 06/03
Traded 06/02